"Amikacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
Descriptor ID |
D000583
|
MeSH Number(s) |
D09.408.051.476.060
|
Concept/Terms |
Amikin- Amikin
- Biklin
- Biclin
- Amiklin
- Amukin
BB-K8- BB-K8
- BB K8
- BBK8
- BB-K 8
- BB K 8
- BBK 8
|
Below are MeSH descriptors whose meaning is more general than "Amikacin".
Below are MeSH descriptors whose meaning is more specific than "Amikacin".
This graph shows the total number of publications written about "Amikacin" by people in this website by year, and whether "Amikacin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2021 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amikacin" by people in Profiles.
-
Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial. Ann Am Thorac Soc. 2021 07; 18(7):1147-1157.
-
Structural and phylogenetic analyses of resistance to next-generation aminoglycosides conferred by AAC(2') enzymes. Sci Rep. 2021 06 02; 11(1):11614.
-
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure. Chest. 2021 09; 160(3):831-842.
-
Cointegration as a mechanism for the evolution of a KPC-producing multidrug resistance plasmid in Proteus mirabilis. Emerg Microbes Infect. 2020 Dec; 9(1):1206-1218.
-
Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice. Antimicrob Agents Chemother. 2019 07; 63(7).
-
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med. 2018 12 15; 198(12):1559-1569.
-
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease. Am J Respir Crit Care Med. 2017 03 15; 195(6):814-823.
-
Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2003 May; 29(5):1014-8.
-
A comparison of two antibiotic regimens for treatment of pelvic inflammatory disease. Obstet Gynecol. 1988 Jul; 72(1):7-12.
-
Characteristics of gentamicin resistance in nosocomial infections. Am J Med Sci. 1980 Jan-Feb; 279(1):25-30.